Published in J Korean Med Sci on December 07, 2012
Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer. J Cardiothorac Surg (2013) 0.99
Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells. Endocr Connect (2014) 0.85
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol (2007) 18.32
Regional lymph node classification for lung cancer staging. Chest (1997) 5.13
International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer (2005) 3.81
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci (2010) 3.79
A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol (2008) 2.01
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg (2001) 1.74
Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest (2000) 1.64
Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer (2005) 1.58
Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol (2011) 1.53
Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis (2004) 1.44
Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg (2000) 1.23
A statistical study of lung cancer in the annual of pathological autopsy cases in Japan, from 1958 to 1997, with reference to time trends of lung cancer in the world. Jpn J Cancer Res (2002) 1.14
Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1,905 cases. Ann Thorac Surg (2001) 0.93
A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer. Surgery (2002) 0.86
Lung cancer among Chinese females in Singapore 1968-1992: time trends, dialect group differences and implications for aetiology. Int J Epidemiol (1998) 0.86
Significant changes in the distribution of histologic types of lung cancer in Hong Kong. Pathology (1993) 0.81
The variation of cell type distribution in lung cancer: a study of 10,910 cases at a medical center in Taiwan between 1970 and 1993. Jpn J Clin Oncol (1996) 0.81
Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study. Lung Cancer (1994) 0.79
[Postoperative results under the new stage classification of lung cancer: the additional reports for those of JACS in 1996]. Kyobu Geka (2000) 0.79
The influence of lung cancer mass screening on surgical results. Lung Cancer (1999) 0.78
High-resolution electrohydrodynamic jet printing. Nat Mater (2007) 2.81
Thoracoscopic lobectomy is associated with superior compliance with adjuvant chemotherapy in lung cancer. Ann Thorac Surg (2011) 1.80
Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer. Ann Thorac Surg (2011) 1.69
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. J Clin Oncol (2012) 1.67
Prognostic value of visceral pleura invasion in non-small cell lung cancer. Eur J Cardiothorac Surg (2003) 1.65
Clinical outcomes and prognosis of recurrent thymoma management. J Thorac Oncol (2012) 1.54
The role of surgical treatment in second primary lung cancer. Ann Thorac Surg (2011) 1.53
Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer (2007) 1.49
Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. Cancer (2011) 1.49
T-stage of non-small cell lung cancer directly invading an adjacent lobe. Eur J Cardiothorac Surg (2012) 1.46
Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Ann Thorac Surg (2008) 1.46
Transcervical intraluminal repair of posterior membranous tracheal laceration through semi-lateral transverse tracheotomy. J Thorac Cardiovasc Surg (2007) 1.37
Surgical treatment of tuberculous cold abscess of the chest wall. Yonsei Med J (2002) 1.27
Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis (2008) 1.26
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Exp Ther Med (2011) 1.26
Retracted Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Yonsei Med J (2012) 1.20
Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg (2004) 1.20
Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment. J Thorac Cardiovasc Surg (2009) 1.15
Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog (2010) 1.12
Basaloid carcinoma of the lung: a really dismal histologic variant? Ann Thorac Surg (2003) 1.11
Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. J Cancer Res Clin Oncol (2009) 1.11
Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer. Cancer (2007) 1.05
Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol (2009) 1.03
Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer. J Cardiothorac Surg (2013) 0.99
The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. Toxicol Sci (2005) 0.99
Thoracoscopic esophagectomy for esophageal cancer: feasibility and safety of robotic assistance in the prone position. J Thorac Cardiovasc Surg (2009) 0.98
Bilateral video-assisted thoracoscopic thymectomy has a surgical extent similar to that of transsternal extended thymectomy with more favorable early surgical outcomes for myasthenia gravis patients. Surg Endosc (2010) 0.98
Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer. Yonsei Med J (2012) 0.98
MMP expression profiling in recurred stage IB lung cancer. Oncogene (2004) 0.97
A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features. Oncol Rep (2008) 0.95
Efficacy of polyglycolic acid sheet after thoracoscopic bullectomy for spontaneous pneumothorax. Ann Thorac Surg (2013) 0.95
A feasibility study of adenosine triphosphate-based chemotherapy response assay (ATP-CRA) as a chemosensitivity test for lung cancer. Cancer Res Treat (2005) 0.95
Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung. Lung Cancer (2012) 0.94
Label-free quantitation of peptide release from neurons in a microfluidic device with mass spectrometry imaging. Lab Chip (2012) 0.94
Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution. Eur J Cardiothorac Surg (2009) 0.93
Nanometer positioning, parallel alignment, and placement of single anisotropic nanoparticles using hydrodynamic forces in cylindrical droplets. Nano Lett (2007) 0.92
Pathologic correlation of serum carcinoembryonic antigen and cytokeratin 19 fragment in resected nonsmall cell lung cancer. Korean J Thorac Cardiovasc Surg (2013) 0.91
Prognostic significance of visceral pleural invasion in the forthcoming (seventh) edition of TNM classification for lung cancer. Lung Cancer (2009) 0.91
Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer. BMC Cancer (2012) 0.91
Surgical resection for pulmonary metastasis from hepatocellular carcinoma: analysis of prognosis in relation to primary control. J Surg Oncol (2010) 0.91
A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer. Lung Cancer (2006) 0.90
Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer. Lung Cancer (2008) 0.89
The prognostic factors of resected non-small cell lung cancer with chest wall invasion. World J Surg Oncol (2012) 0.89
Contralateral cerebral infarction after stent placement in carotid artery: an unexpected complication. J Korean Neurosurg Soc (2008) 0.88
Microfluidic device for the selective chemical stimulation of neurons and characterization of peptide release with mass spectrometry. Anal Chem (2012) 0.88
World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Hum Pathol (2010) 0.88
Connecting single molecule electrical measurements to ensemble spectroscopic properties for quantification of single-walled carbon nanotube separation. J Am Chem Soc (2009) 0.87
Identification of tumor suppressor loci on the long arm of chromosome 4 in primary small cell lung cancers. Yonsei Med J (2002) 0.86
Early and Long-term Outcomes of Pneumonectomy for Treating Sequelae of Pulmonary Tuberculosis. Korean J Thorac Cardiovasc Surg (2012) 0.86
Complete stable remission after extended transsternal thymectomy in myasthenia gravis. Eur J Cardiothorac Surg (2006) 0.84